medicrea
-
Financial
Medtronic Completes Acquisition of Medicrea
DUBLIN – November 16, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has completed…
Read More » -
Financial
MEDICREA Reports Third Quarter 2020 Sales
October 8, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Financial
Medtronic to Acquire Medicrea
July 15, 2020 DUBLIN & LYON, France–(BUSINESS WIRE)–Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth…
Read More » -
Financial
MEDICREA Reports First Half 2020 Sales
July 9, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
COVID-19
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
March 20, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Regulatory
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
February 11, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX :…
Read More » -
Spine
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
February 03, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX :…
Read More » -
Financial
MEDICREA® Reports 2019 Annual Sales
January 15, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Spine
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
January 13, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Regulatory
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors
January 06, 2020 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Financial
Medicrea Reports Third Quarter 2019 Financial Results
November 13, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF),…
Read More » -
Regulatory
MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI platform technology
August 02, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Spine
MEDICREA® Enhances Its Proprietary UNiD ASI™ Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service
April 18, 2019 LYON & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED; OTCQX Best Market –…
Read More » -
Financial
Medicrea Reports 2018 Annual Results
March 22, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF),…
Read More » -
Financial
Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum
January 16, 2019 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF),…
Read More »